Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-28T22:58:46.390Z Has data issue: false hasContentIssue false
  • English
  • Français

Microembolic Signals in Patients with Systemic Lupus Erythematosus

Published online by Cambridge University Press:  02 December 2014

Mahmoud Reza Azarpazhooh ,
Naghmeh Mokhber ,
Elias Orouji ,
Brian R. Chambers ,
Mohammad Reza Hatef ,
Zahra Rezaieyazdi ,
Sima Sedighi ,
Mohsen Foroghipoor ,
Arash Velayati  and
Morteza Modares Gharavi
Mahmoud Reza Azarpazhooh
Affiliation:
Department of Neurology, Mashhad, Iran
Naghmeh Mokhber
Affiliation:
Department of Psychiatry, Avicenna Hospital, Mashhad, Iran
Elias Orouji
Affiliation:
Mashhad University of Medical Sciences, Mashhad, Iran
Brian R. Chambers
Affiliation:
Austin Health, National Stroke Research Institute, Victoria, Australia
Mohammad Reza Hatef*
Affiliation:
Department of Rheumatology, Emam Reza Hospital, Mashhad, Iran
Zahra Rezaieyazdi
Affiliation:
Department of Rheumatology, Ghaem Medical Center, Mashhad, Iran
Sima Sedighi
Affiliation:
Department of Rheumatology, Ghaem Medical Center, Mashhad, Iran
Mohsen Foroghipoor
Affiliation:
Department of Neurology, Mashhad, Iran
Arash Velayati
Affiliation:
Department of Neurology, Mashhad, Iran
Morteza Modares Gharavi
Affiliation:
Department of Psychiatry, Avicenna Hospital, Mashhad, Iran
*
Department of Neurology, Ghaem Medical Center, Mashhad University of Medical Science, Taghi Abad Square, Mashhad, Iran.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

Central nervous system (CNS) involvement is a common and less understood aspect of systemic lupus erythematosus (SLE). Microembolic signals (MES) have been reported in SLE. We conducted a prospective study to evaluate the frequency of MES among patients with CNS involvement and those without. The main aim of the study is to clarify the pathophysiology of the CNS involvement in SLE.

Methods and Materials:

Sixty eight patients with a diagnosis of SLE (60 females, 8 males) participated in the study. Both middle cerebral arteries were monitored using transcranial Doppler for 60 min to detect MES. All cases underwent neurology and psychiatry assessments.

Results:

MES were detected in 7/68 patients (10.3%) with the mean number of 3.5 per hour. MES were significantly higher in patients with CNS involvement (6/24, 25%) than those without (1/44, 2.2%) (P=0.006). SLE disease activity index, duration of disease, plaque formation, intima-media thickness, and antiphospholipid antibodies were not associated with MES. MES were more frequent in patients receiving Aspirin and/or Warfarin (p=0.02).

Conclusions:

MES may be a predictor for CNS involvement in SLE patients at risk for neuropsychiatric syndromes. Cerebral embolism may be implicated in the pathophysiology of neuropsychiatric SLE.

Type
Original Article
Information
Canadian Journal of Neurological Sciences , Volume 37 , Issue 3 , May 2010 , pp. 371 - 375
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Sibley, JT, Olszynski, WP, Decoteau, WE, Sundaram, MB. Incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol. 1992;19(1):47–52.Google Scholar
2. Ainiala, H, Loukkola, J, Peltola, J, Korpela, M, Hietaharju, A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57(3):496–500.Google Scholar
3. Hanly, JG, Walsh, NM, Sangalang, V. Brain pathology in systemic lupus erythematosus. J Rheumatol. 1992;19(5):732–41.Google Scholar
4. Omdal, R. Some controversies of neuropsychiatric systemic lupus erythematosus. Scand J Rheumatol. 2002;31(4):192–7.Google Scholar
5. Harris, EN, Pierangeli, S. Antiphospholipid antibodies and cerebral lupus. Ann NY Acad Sci. 1997;823:270–8.CrossRefGoogle ScholarPubMed
6. Pope, JM, Canny, CL, Bell, DA. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med. 1991;909(3):299–309.Google Scholar
7. Steinlin, MI, Blaser, SI, Gilday, DL, Eddy, AA, Logan, WJ, Laxer, RM, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol. 1995;13(3):191–7.Google Scholar
8. Sabbadini, MG, Manfredi, AA, Bozzolo, E, Ferrario, L, Rugarli, C, Scorza, R, et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus. 1999;8(1):11–19.Google Scholar
9. Tam, LS, Fan, B, Li, EK, Thomas, GN, Yim, SF, Haines, CJ, et al. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia. J Rheumatol. 2003;30(7):1479–84.Google ScholarPubMed
10. Devinsky, O, Petito, CK, Alonso, DR. Clinical and neuropathological findings in systemic lupus erythematosus; the role of vasculitis, heart emboli and thrombotic thrombocytopenic purpura. Ann Neurol. 1988;23(4):380–4.Google Scholar
11. Krause, I, Lev, S, Fraser, A, Blank, M, Lorber, M, Stojanovich, L, et al. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis. 2005;64(10):1490–3.Google Scholar
12. Love, PE, Santoro, SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990;112(2):682–98.Google Scholar
13. Petri, M. Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective. Scand J Rheumatol. 1996;25(4):191–3.Google Scholar
14. Petri, M, Roubenoff, R, Dallal, GE, Nadeau, MR, Selhub, J, Rosenberg, IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet. 1996;348(9035):1120–4.Google Scholar
15. Azarpazhooh, MR, Chambers, BR. Clinical application of transcranial Doppler monitoring for embolic signals. J Clin Neurosci. 2006;13(8):799–810.Google Scholar
16. Rademacher, J, Söhngen, D, Specker, C, Janda, I, Sitzer, M. Cerebral microembolism, a disease marker for ischemic cerebrovascular events in the antiphospholipid syndrome of systemic lupus erythematosus? Acta Neurol Scand. 1999;99(6):356–61.Google Scholar
17. Kron, J, Hamper, UM, Petri, M. Prevalence of cerebral microemboli in systemic lupus erythematosus: transcranial Doppler. J Rheumatol. 2001;28(10):2222–5.Google Scholar
18. Kumral, E, Evyapan, D, Keser, G, Kabasakal, Y, Oksel, F, Aksu, K, et al. Detection of microembolic signals in patients with neuropsychiatric lupus erythematosus. Eur Neurol. 2002;47(3):131–5.Google Scholar
19. Dahl, A, Omdal, R, Waterloo, K, Joakimsen, O, Jacobsen, EA, Koldingsnes, W, et al. Detection of cerebral embolic signals in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 2006;77(6):774–9 Google Scholar
20. Tan, EM, Cohen, AS, Fries, JF, Masi, AT, McShane, DJ, Rothfield, NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271–7.Google Scholar
21. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and care definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999; 42: 599–608.Google Scholar
22. Bombardier, C, Gladman, DD, Urowitz, MB, Caron, D, Chang, CH. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35(6):630–40.Google Scholar
23. Groth-Marnat, G. Handbook of psychological assessment, 4th ed. Hoboken, New Jersey: John Wily and Sons, Inc.; 2003.Google Scholar
24. Azarpazhooh, MR, Velayati, A, Chambers, BR, Mashhadi Nejad, H, Sasan Nejad, P. Microembolic signals in subarachnoid hemorrhage. J Clin Neurosci. 2009;16(3):390–3.CrossRefGoogle ScholarPubMed
25. Consensus Committee of the Ninth International Cerebral Hemodynamic Symposium. Basic identification criteria of Doppler microembolic signals. Stroke. 1995;26:1123.Google Scholar
26. Markus, HS, Ackerstaff, R, Babikian, V, Bladin, C, Droste, D, Grosset, D, et al. Intercenter agreement in reading Doppler embolic signals. A multicenter international study. Stroke. 1997;28(7): 1307–10.Google Scholar
27. Roman, MJ, Moeller, E, Davis, A, Paget, SA, Crow, MK, Lockshin, MD, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006; 144(4):249–56.Google Scholar
28. Specker, C, Rademacher, J, Söhngen, D, Sitzer, M, Janda, I, Siebler, M, et al. Cerebral microemboli in patients with antiphospholipid syndrome. Lupus. 1997;6(8):638–44.Google Scholar
29. Sitzer, M, Söhngen, D, Siebler, M, Specker, C, Rademacher, J, Janda, I, et al. Cerebral microembolism in patients with Sneddon’s syndrome. Arch Neurol. 1995;52(3): 271–5.Google Scholar